A detailed history of Susquehanna Fundamental Investments, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 126,164 shares of ALEC stock, worth $553,859. This represents 0.04% of its overall portfolio holdings.

Number of Shares
126,164
Holding current value
$553,859
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$5.69 - $8.08 $717,873 - $1.02 Million
126,164 New
126,164 $760 Million
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $62,249 - $104,985
-11,971 Reduced 16.73%
59,563 $385,000
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $492,153 - $683,149
71,534 New
71,534 $660,000
Q3 2020

Nov 16, 2020

SELL
$10.54 - $24.96 $90,643 - $214,656
-8,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$21.87 - $33.11 $188,082 - $284,746
8,600 New
8,600 $210,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $362M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.